Physician
Naples Pathology Associates PA
Naples Pathology Associates PA was paid $3.06M by Medicaid between Jan 2018 and Nov 2024, across 126 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 20% of everything it billed.
33Billing provider infoNAPLES PATHOLOGY ASSOCIATES PA
NAPLES, FL 34102
NAPLES, FL 34102
33aNPI1679547756assigned 02/15/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$3.06M
24GClaims648,157
24DCodes billed126
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#9 of 207
Median peer was paid$39K
This provider vs. median78×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,687 | $35K | |
| 2019 | 100,224 | $154K | |
| 2020 | 101,643 | $216K | |
| 2021 | 120,944 | $606K | |
| 2022 | 114,754 | $1.40M | |
| 2023 | 109,502 | $417K | |
| 2024incomplete | 64,403 | $233K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 20% | 2,027 | 1,965 | $601K |
| 87486 | 14% | 11,093 | 10,693 | $431K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 14% | 1,433 | 1,329 | $413K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 11% | 4,786 | 4,702 | $326K |
| 80053 | Comprehensive metabolic panel | 4.4% | 33,710 | 20,472 | $133K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.1% | 11,605 | 11,093 | $94K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 2,321 | 2,207 | $82K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.5% | 3,599 | 3,165 | $78K |
| 82805 | 2.3% | 4,176 | 1,866 | $70K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.3% | 2,095 | 1,793 | $69K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.2% | 48,453 | 20,451 | $68K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 4,403 | 2,890 | $59K |
114 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 52,314 | $41K |
| 80076 | 1.3% | 11,122 | $41K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.1% | 9,231 | $34K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 9,781 | $31K |
| 87581 | <1% | 11,091 | $28K | |
| 85027 | <1% | 36,921 | $27K | |
| 84484 | <1% | 15,484 | $22K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,687 | $20K |
| 83735 | <1% | 29,939 | $20K | |
| 86920 | <1% | 1,483 | $19K | |
| 87040 | <1% | 8,357 | $19K | |
| 86850 | <1% | 9,190 | $16K | |
| 82947 | <1% | 7,957 | $13K | |
| 87634 | <1% | 1,894 | $13K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 200 | $12K |
| 84702 | <1% | 3,500 | $11K | |
| 85730 | <1% | 17,131 | $11K | |
| 83605 | <1% | 10,172 | $10K | |
| 87186 | <1% | 4,304 | $10K | |
| 87081 | <1% | 10,981 | $10K | |
| 83540 | <1% | 1,230 | $10K | |
| 87077 | <1% | 5,942 | $10K | |
| 83690 | <1% | 13,676 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,808 | $8K |
| 85610 | <1% | 22,746 | $8K | |
| 82247 | <1% | 6,392 | $8K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 914 | $8K |
| 87428 | <1% | 552 | $7K | |
| 82553 | <1% | 3,996 | $7K | |
| 86901 | <1% | 14,230 | $7K | |
| 81001 | <1% | 19,614 | $7K | |
| 85379 | <1% | 4,945 | $7K | |
| 87070 | <1% | 3,016 | $7K | |
| 83520 | <1% | 5,341 | $7K | |
| 82330 | <1% | 5,147 | $6K | |
| 86880 | <1% | 1,577 | $6K | |
| 85007 | <1% | 9,607 | $6K | |
| 86140 | <1% | 10,996 | $6K | |
| 80061 | Lipid panel | <1% | 1,512 | $6K |
| 84100 | <1% | 13,575 | $6K | |
| 81025 | <1% | 6,131 | $6K | |
| 82248 | <1% | 9,334 | $5K | |
| 86900 | <1% | 12,027 | $5K | |
| 81003 | <1% | 11,309 | $4K | |
| 80320 | <1% | 2,317 | $4K | |
| 82550 | <1% | 6,700 | $4K | |
| 88307 | <1% | 78 | $4K | |
| 87427 | <1% | 477 | $3K | |
| 83880 | <1% | 997 | $3K | |
| 87449 | <1% | 279 | $3K | |
| 82803 | <1% | 2,480 | $3K | |
| 83615 | <1% | 4,581 | $2K | |
| 87045 | <1% | 1,466 | $2K | |
| 82150 | <1% | 4,036 | $2K | |
| 87205 | <1% | 3,285 | $2K | |
| 80202 | <1% | 1,045 | $2K | |
| 85652 | <1% | 3,858 | $1K | |
| 86592 | <1% | 1,977 | $1K | |
| 80329 | <1% | 1,072 | $1K | |
| 82962 | <1% | 2,186 | $1K | |
| 82140 | <1% | 966 | $1K | |
| 85045 | <1% | 1,558 | $1K | |
| 82375 | <1% | 860 | $1K | |
| 85384 | <1% | 1,774 | $1K | |
| 88342 | <1% | 38 | $1K | |
| 82565 | <1% | 2,058 | $974.86 | |
| 88304 | <1% | 85 | $948.10 | |
| 84550 | <1% | 2,562 | $911.22 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 897 | $894.60 |
| 84703 | <1% | 1,575 | $836.30 | |
| 83050 | <1% | 838 | $801.28 | |
| 82728 | <1% | 631 | $789.09 | |
| 87075 | <1% | 595 | $788.69 | |
| 87210 | <1% | 730 | $753.78 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 55 | $720.78 |
| 86870 | <1% | 96 | $481.96 | |
| 82607 | <1% | 318 | $474.96 | |
| 85014 | <1% | 2,331 | $472.10 | |
| 84132 | <1% | 954 | $456.41 | |
| 84460 | <1% | 899 | $413.86 | |
| 84478 | <1% | 931 | $393.93 | |
| 84466 | <1% | 292 | $368.86 | |
| 84450 | <1% | 871 | $296.73 | |
| 86308 | <1% | 443 | $285.54 | |
| 85018 | <1% | 1,692 | $246.32 | |
| 87899 | <1% | 280 | $238.57 | |
| 84295 | <1% | 610 | $196.98 | |
| 84156 | <1% | 467 | $154.29 | |
| 84520 | <1% | 677 | $150.20 | |
| 84436 | <1% | 295 | $144.21 | |
| 86706 | <1% | 92 | $140.54 | |
| 83550 | <1% | 155 | $140.52 | |
| 80069 | <1% | 191 | $127.11 | |
| 87340 | <1% | 145 | $119.89 | |
| 84479 | <1% | 197 | $110.90 | |
| 85060 | <1% | 18 | $72.87 | |
| 84145 | <1% | 305 | $72.27 | |
| 87102 | <1% | 31 | $65.37 | |
| 84439 | <1% | 123 | $60.96 | |
| 82570 | <1% | 45 | $52.70 | |
| 88300 | <1% | 14 | $50.08 | |
| 80170 | <1% | 51 | $48.06 | |
| 89051 | <1% | 78 | $40.16 | |
| 87147 | <1% | 39 | $30.72 | |
| 87116 | <1% | 82 | $30.60 | |
| 82945 | <1% | 73 | $27.58 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 19 | $17.71 |
| 82040 | <1% | 23 | $12.20 | |
| 87206 | <1% | 82 | $12.15 | |
| 84157 | <1% | 48 | $10.96 | |
| 82270 | <1% | 34 | $7.23 | |
| 82977 | <1% | 13 | $5.65 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 13 | $0.00 |
| 82077 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJEWELL, THOMAS (PRESIDENT NAPLES PATHOLOGY ASSOC)